← Open Payments lookup

MADELYN DOOLEY: Open Payments

NPI 1851783864 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$900 in 55 payments from 18 companies in 2025. Trend: 2023 $164 · 2024 $2,509 · 2025 $900

Food & beverage: $900
CompanyPaymentsAmount
Dexcom, Inc.16$193
Amgen Inc.10$149
Insulet Corporation5$118
Tandem Diabetes Care, Inc.4$56
Abbott Laboratories2$50
Neurocrine BioSciences, Inc.2$44
Xeris Pharmaceuticals, Inc.2$41
SANOFI-AVENTIS U.S. LLC2$39
Corcept Therapeutics2$32
RECORDATI_RARE_DISEASES_INC.2$31

Products named: Dexcom G6 Transmitter, Omnipod, TEPEZZA, t:slim X2 Insulin Pump with Control-IQ, TAVNEOS, FREESTYLE LIBRE 3, CRENESSITY, RECORLEV.

Industry payments across LA — which companies pay providers there.